This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 – 29, 2020.
At the end of this CME/CE activity, participants should be able to analyze the latest clinical evidence on the use of MOUD, and its various formulations and routes of delivery, to promote long-term recovery and relapse prevention.
This activity is supported by an educational grant from Alkermes, Inc.
Physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold reports that he is a consultant for ADAPT Pharma (Dublin, Ireland).
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty has been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number 0376-0000-20-088-H01-P.
Call us at 877.CME.PROS (877.263.7767).